Andrew Huberman· PhD
And so now we're talking about something totally different. We're talking about delivering crisper. not the an mRNA vaccine, but we're talking about how would we get crisper into cells or how would we get extra pieces of genetic material which might be an mRNA so into a T- cell. All of this can now be done even beyond the vaccine world with the same kind of building blocks of technologies like lipid nanoparticles.